Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shahryar Khoshtinat Nikkhoi, Ph.D.

Concepts (56)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Shahryar Khoshtinat Nikkhoi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Shahryar Khoshtinat Nikkhoi has written about over time.
Doxorubicin, 1 publications between 2018 and 2018, average publication date April 2018. Oligoclonal Bands, 1 publications between 2018 and 2018, average publication date April 2018. Polyethylene Glycols, 2 publications between 2018 and 2018, average publication date May 2018. Receptor, ErbB-2, 2 publications between 2018 and 2018, average publication date May 2018. Immunoglobulin Heavy Chains, 1 publications between 2018 and 2018, average publication date June 2018. Methotrexate, 1 publications between 2018 and 2018, average publication date June 2018. Azurin, 1 publications between 2019 and 2019, average publication date March 2019. Cell Line, Tumor, 4 publications between 2018 and 2021, average publication date May 2019. Liposomes, 3 publications between 2018 and 2021, average publication date June 2019. Antigens, Bacterial, 1 publications between 2021 and 2021, average publication date September 2021. Bacterial Toxins, 1 publications between 2021 and 2021, average publication date September 2021. Integrin alpha4beta1, 1 publications between 2021 and 2021, average publication date September 2021. Integrin alpha5beta1, 1 publications between 2021 and 2021, average publication date September 2021. Integrin alpha6beta1, 1 publications between 2021 and 2021, average publication date September 2021. Single-Chain Antibodies, 1 publications between 2022 and 2022, average publication date August 2022. Antibody-Dependent Cell Cytotoxicity, 1 publications between 2024 and 2024, average publication date March 2024. Killer Cells, Natural, 1 publications between 2024 and 2024, average publication date March 2024. Ovarian Neoplasms, 1 publications between 2024 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
Khoshtinat Nikkhoi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.